Fudan-Zhangjiang Bio-Pharma Turns Profitable in Nine Months
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Banco Santander-Chile Reports Q3 Net Income of $0.50 per ADR
M impact | EARNINGS | Oct 30, 2026, 11:08 AM UTC
BP Operating Earnings Top Consensus by 10%, Adjusted Net Income by 15%
UBS analyst Joshua Stone says BP's operating earnings came in 10% ahead of consensus and adjusted net income beat by 15%.
H impact | EARNINGS | Oct 30, 2026, 11:06 AM UTC
General Dynamics earnings above expectations at 4.49 USD
General Dynamics (GD) released earnings per share at 4.49 USD, compared to market expectations of 4.06 USD.
H impact | EARNINGS | Oct 30, 2026, 11:04 AM UTC
Exelon earnings below expectations at 0.87 USD
Exelon (EXC) released earnings per share at 0.87 USD, compared to market expectations of 0.89 USD.
H impact | EARNINGS | Oct 30, 2026, 11:00 AM UTC
Church & Dwight Reports 3Q Net Income of $212.2M
M impact | EARNINGS | Oct 30, 2026, 10:55 AM UTC
Colgate-Palmolive reports third-quarter net income of $751 million
H impact | EARNINGS | Oct 30, 2026, 10:55 AM UTC